2022
Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy
Bhardwaj P, Gota V, Vishwakarma K, Pai V, Chaudhari P, Mohanty B, Thorat R, Yadav S, Gurjar M, Goda JS, Banerjee R. Loco-regional radiosensitizing nanoparticles-in-gel augments head and neck cancer chemoradiotherapy. Journal Of Controlled Release 2022, 343: 288-302. PMID: 35101477, DOI: 10.1016/j.jconrel.2022.01.040.Peer-Reviewed Original Research
2020
Multifunctional Core–Shell Glyconanoparticles for Galectin-3-Targeted, Trigger-Responsive Combination Chemotherapy
Balakrishnan B, Subramanian S, Mallia MB, Repaka K, Kaur S, Chandan R, Bhardwaj P, Dash A, Banerjee R. Multifunctional Core–Shell Glyconanoparticles for Galectin-3-Targeted, Trigger-Responsive Combination Chemotherapy. Biomacromolecules 2020, 21: 2645-2660. PMID: 32484667, DOI: 10.1021/acs.biomac.0c00358.Peer-Reviewed Original ResearchConceptsCore-shell nanoparticlesTarget specific drug releaseMultivalent ligand presentationCombination drug deliveryBoronate estersDrug releaseSchiff baseMDA-MB-231 cancer cellsCitrus pectinDrug deliveryNanoparticlesPlacebo nanoparticlesProof of conceptPeriodate oxidationLigand presentationGlyconanoparticlesVivo monitoringEnhanced internalizationTarget specificityGastric tractTriple-negative MDA-MB-231 breast cancer cellsBiodistribution studiesHomotypic cellular aggregationDoxorubicinShell
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply